Stocks and Investing Stocks and Investing
Mon, July 2, 2018
[ 12:00 AM ] - WOPRAI
Julien Dumoulin-Smith Downgraded (AES) to Sell and Increased Target to $13 on, Jul 2nd, 2018
[ 12:00 AM ] - WOPRAI
Meta Marshall Downgraded (BAND) to Hold on, Jul 2nd, 2018
[ 12:00 AM ] - WOPRAI
Betsy Graseck Upgraded (WFC) to Hold and Increased Target to $62 on, Jul 2nd, 2018
[ 12:00 AM ] - WOPRAI
Mehdi Hosseini Upgraded (TSM) to Buy on, Jul 2nd, 2018
[ 12:00 AM ] - WOPRAI
Mark Swartzberg Maintained (STZ) at Hold with Decreased Target to $224 on, Jul 2nd, 2018
[ 12:00 AM ] - WOPRAI
Betsy Graseck Maintained (STT) at Hold with Decreased Target to $113 on, Jul 2nd, 2018
Fri, June 29, 2018
[ 12:00 AM ] - WOPRAI
Brian Bedell Maintained (STT) at Strong Buy with Decreased Target to $115 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Sheng Zhong Downgraded (TAL) to Hold on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Omotayo Okusanya Maintained (WELL) at Hold with Increased Target to $64 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Eric Coldwell Downgraded (WBA) to Hold on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Devin Dodge Maintained (WCN) at Buy with Increased Target to $84 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Matt Sheerin Maintained (SNX) at Strong Buy with Decreased Target to $130 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
David Ross Initiated (SNDR) at Hold and Held Target at $29 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Kenneth Herbert Maintained (TDG) at Strong Buy with Increased Target to $375 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Robert Spingarn Maintained (TDG) at Buy with Increased Target to $400 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Sheila Kahyaoglu Maintained (TDG) at Hold with Increased Target to $350 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Carlos De Alba Maintained (TECK) at Hold with Increased Target to $29 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
David Katz Maintained (WYNN) at Strong Buy with Decreased Target to $229 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Erik Zwick Initiated (BWFG) at Buy and Held Target at $37 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Brian Tanquilut Downgraded (THC) to Hold and Increased Target to $38 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Richard Davis Maintained (UPLD) at Strong Buy with Increased Target to $38 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Chris Brendler Upgraded (AXP) to Strong Buy and Increased Target to $112 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Thomas Gallagher Upgraded (BHF) to Buy on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Bryan Keane Maintained (ACN) at Strong Buy with Increased Target to $170 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Jason Kupferberg Downgraded (ACN) to Hold on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Joseph Foresi Maintained (ACN) at Buy with Increased Target to $185 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Ashwin Shirvaikar Maintained (ACN) at Hold with Increased Target to $163 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Charles Brennan Maintained (ACN) at Hold with Increased Target to $160 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Brent Thielman Downgraded (APOG) to Hold and Increased Target to $52 on, Jun 29th, 2018
[ 12:00 AM ] - WOPRAI
Arlinda Lee Maintained (CARA) at Strong Buy with Increased Target to $22 on, Jun 29th, 2018

Arlinda Lee Maintained (CARA) at Strong Buy with Increased Target to $22 on, Jun 29th, 2018


Published on 2024-10-26 06:28:51 - WOPRAI, Arlinda Lee
  Print publication without navigation


Arlinda Lee of Canaccord Genuity, Maintained "Cara Therapeutics, Inc." (CARA) at Strong Buy with Increased Target from $21 to $22 on, Jun 29th, 2018.

Arlinda has made no other calls on CARA in the last 4 months.



There is 1 other peer that has a rating on CARA. Out of the 1 peers that are also analyzing CARA, 0 agree with Arlinda's Rating of Hold.



This is the rating of the analyst that currently disagrees with Arlinda

  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $24 on, Wednesday, May 23rd, 2018
Contributing Sources